Eye drop instillation technique in patients with glaucoma

Eye (Basingstoke)

Volumn 27, Issue 11, 2013, Pages 1293-1298

  Tatham, A J ^a   Sarodia, U ^a   Gatrad, F ^a   Awan, A ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

compliance; drop instillation; education; eye drop; glaucoma; medical treatment

Indexed keywords

ARTIFICIAL TEAR; EYE DROPS;

ADULT; AGED; ARTICLE; CONJUNCTIVA; CORNEA; DRUG INSTILLATION; EYELASH; EYELID; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GLAUCOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; SELF CARE;

EID: 84887655680     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2013.187     Document Type: Article

References (23)

1. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986; 101: 515-523.
2. Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990; 74: 477-480.
3. Granström PA. Glaucoma patients not compliant with their drug therapy: Clinical and behavioural aspects. Br J Ophthalmol 1982; 66: 464-470.
4. Lu VH, Goldberg I, Lu CY. Use of glaucoma medications: State of the science and directions for observational research. Am J Ophthalmol 2010; 150: 569-574.
5. Stryker JE, Beck AD, Primo SA, Echt KV, Bundy L, Pretorius GC et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma 2010; 19: 66-72.
6. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: A systematic classification. J Glaucoma. 2003; 12: 393-398.
7. Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology 2011; 118: 2398-2402.
8. Kass MA, Hodapp E, Gordon M, Kolker AE, Goldberg I. Part I. Patient administration of eyedrops: Interview. Ann Ophthalmol 1982; 14: 775-779.
9. Fraunfelder FT. Extraocular fluid dynamics: How best to apply topical ocular medication. Trans Am Ophthalmol Soc 1976; 74: 457-487.
10. Zimmerman TJ, Kooner KS, Kandarakis AS, Ziegler LP. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol 1984; 102: 551-553.
11. Tsai T, Robin AL, Smith III, JP. An evaluation of how glaucoma patients use topical medications: A pilot study. Trans Am Ophthalmol Soc 2007; 105: 29-35.
12. Geyer O, Bottone EJ, Podos SM, Schumer RA, Asbell PA. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol 1995; 79: 376-379.
13. Brown MM, Brown GC, Spaeth GL. Improper topical self-administration of ocular medication among patients with glaucoma. Can J Ophthalmol 1984; 19: 2-5.
14. Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma 2012; 21: 189-192.
15. Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol 2008; 43: 454-461.
16. Dietlein TS, Jordan JF, Luke C, Schild A, Dinslage S, Krieglstein GK. Self-application of single-use eyedrop containers in an elderly population: Comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol 2008; 86: 856-859.
17. Cohen J. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213-220.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
19. Kim MS, Choi CY, Kim JM, Woo HY. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. Br J Ophthalmol 2008; 92: 1518-1521.
20. Schein OD,Wasson PJ, Boruchoff SA, Kenyon KR. Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol 1988; 15(105): 361-365.
21. Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol 2009; 127: 732-736.
22. Nordmann JP, Baudouin C, Bron A, Denis P, Rouland JF, Sellem E et al. Xal-Ease: Impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction. Eur J Ophthalmol 2009; 19: 949-956.
23. Salyani A, Birt C. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication. Can J Ophthalmol 2005; 40: 170-174.